vs
APOGEE ENTERPRISES, INC.（APOG）とPediatrix Medical Group, Inc.（MD）の財務データ比較。上の社名をクリックして会社を切り替えられます
Pediatrix Medical Group, Inc.の直近四半期売上が大きい（$493.8M vs $351.4M、APOGEE ENTERPRISES, INC.の約1.4倍）。Pediatrix Medical Group, Inc.の純利益率が高く（6.8% vs 4.7%、差は2.1%）。APOGEE ENTERPRISES, INC.の前年同期比売上増加率が高い（1.6% vs -1.7%）。過去8四半期でAPOGEE ENTERPRISES, INC.の売上複合成長率が高い（2.9% vs -0.1%）
Apogee Enterprisesはアメリカのオーディオ機器メーカーです。オーディオインターフェース、AD/DAコンバーター、USB・iOS対応マイクの製造を主軸に、オーディオ制作向けソフトウェアの開発も手がけており、プロの録音や音楽制作分野で広く利用されています。
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
APOG vs MD — 直接比較
損益計算書 — Q4 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $351.4M | $493.8M |
| 純利益 | $16.6M | $33.7M |
| 粗利率 | 22.4% | — |
| 営業利益率 | 7.3% | 9.9% |
| 純利益率 | 4.7% | 6.8% |
| 売上前年比 | 1.6% | -1.7% |
| 純利益前年比 | 568.8% | 10.5% |
| EPS（希薄化後） | $0.78 | $0.40 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $351.4M | — | ||
| Q4 25 | $348.6M | $493.8M | ||
| Q3 25 | $358.2M | $492.9M | ||
| Q2 25 | $346.6M | $468.8M | ||
| Q1 25 | $345.7M | $458.4M | ||
| Q4 24 | $341.3M | $502.4M | ||
| Q3 24 | $342.4M | $511.2M | ||
| Q2 24 | $331.5M | $504.3M |
| Q1 26 | $16.6M | — | ||
| Q4 25 | $16.5M | $33.7M | ||
| Q3 25 | $23.6M | $71.7M | ||
| Q2 25 | $-2.7M | $39.3M | ||
| Q1 25 | $2.5M | $20.7M | ||
| Q4 24 | $21.0M | $30.5M | ||
| Q3 24 | $30.6M | $19.4M | ||
| Q2 24 | $31.0M | $-153.0M |
| Q1 26 | 22.4% | — | ||
| Q4 25 | 23.8% | — | ||
| Q3 25 | 23.1% | — | ||
| Q2 25 | 21.7% | — | ||
| Q1 25 | 21.6% | — | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 28.4% | — | ||
| Q2 24 | 29.8% | — |
| Q1 26 | 7.3% | — | ||
| Q4 25 | 7.1% | 9.9% | ||
| Q3 25 | 7.5% | 13.8% | ||
| Q2 25 | 2.0% | 12.8% | ||
| Q1 25 | 1.8% | 7.0% | ||
| Q4 24 | 8.4% | 7.8% | ||
| Q3 24 | 12.3% | 6.6% | ||
| Q2 24 | 12.5% | -31.3% |
| Q1 26 | 4.7% | — | ||
| Q4 25 | 4.7% | 6.8% | ||
| Q3 25 | 6.6% | 14.5% | ||
| Q2 25 | -0.8% | 8.4% | ||
| Q1 25 | 0.7% | 4.5% | ||
| Q4 24 | 6.1% | 6.1% | ||
| Q3 24 | 8.9% | 3.8% | ||
| Q2 24 | 9.4% | -30.3% |
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.77 | $0.40 | ||
| Q3 25 | $1.10 | $0.84 | ||
| Q2 25 | $-0.13 | $0.46 | ||
| Q1 25 | $0.12 | $0.24 | ||
| Q4 24 | $0.96 | $0.37 | ||
| Q3 24 | $1.40 | $0.23 | ||
| Q2 24 | $1.41 | $-1.84 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $39.5M | $375.2M |
| 総負債低いほど良い | $232.3M | $570.5M |
| 株主資本純資産 | $511.8M | $865.9M |
| 総資産 | $1.1B | $2.2B |
| 負債/資本比率低いほどレバレッジが低い | 0.45× | 0.66× |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $39.5M | — | ||
| Q4 25 | $41.3M | $375.2M | ||
| Q3 25 | $39.5M | $340.1M | ||
| Q2 25 | $32.8M | $224.7M | ||
| Q1 25 | $41.4M | $99.0M | ||
| Q4 24 | $43.9M | $229.9M | ||
| Q3 24 | $51.0M | $103.8M | ||
| Q2 24 | $30.4M | $19.4M |
| Q1 26 | $232.3M | — | ||
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | $285.0M | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $511.8M | — | ||
| Q4 25 | $512.3M | $865.9M | ||
| Q3 25 | $500.2M | $890.7M | ||
| Q2 25 | $481.8M | $833.8M | ||
| Q1 25 | $487.9M | $789.2M | ||
| Q4 24 | $522.1M | $764.9M | ||
| Q3 24 | $506.4M | $732.5M | ||
| Q2 24 | $480.0M | $706.5M |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $2.2B | ||
| Q3 25 | $1.2B | $2.2B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.2B | $2.0B | ||
| Q4 24 | $1.2B | $2.2B | ||
| Q3 24 | $917.1M | $2.1B | ||
| Q2 24 | $889.0M | $2.0B |
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | 0.58× | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $122.5M | $114.1M |
| フリーキャッシュフロー営業CF - 設備投資 | — | — |
| FCFマージンFCF / 売上 | — | — |
| 設備投資強度設備投資 / 売上 | 7.8% | — |
| キャッシュ転換率営業CF / 純利益 | 7.37× | 3.39× |
| 直近12ヶ月FCF直近4四半期 | — | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $122.5M | — | ||
| Q4 25 | $29.3M | $114.1M | ||
| Q3 25 | $57.1M | $137.3M | ||
| Q2 25 | $-19.8M | $137.2M | ||
| Q1 25 | $30.0M | $-117.5M | ||
| Q4 24 | $31.0M | $133.0M | ||
| Q3 24 | $58.7M | $91.8M | ||
| Q2 24 | $5.5M | $107.0M |
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | — | ||
| Q3 25 | $52.4M | — | ||
| Q2 25 | $-26.9M | — | ||
| Q1 25 | $19.1M | — | ||
| Q4 24 | $22.0M | — | ||
| Q3 24 | $50.2M | — | ||
| Q2 24 | $-1.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | — | ||
| Q3 25 | 14.6% | — | ||
| Q2 25 | -7.8% | — | ||
| Q1 25 | 5.5% | — | ||
| Q4 24 | 6.4% | — | ||
| Q3 24 | 14.7% | — | ||
| Q2 24 | -0.5% | — |
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 2.2% | — |
| Q1 26 | 7.37× | — | ||
| Q4 25 | 1.77× | 3.39× | ||
| Q3 25 | 2.41× | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | 12.08× | -5.66× | ||
| Q4 24 | 1.48× | 4.36× | ||
| Q3 24 | 1.92× | 4.72× | ||
| Q2 24 | 0.18× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
